These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 5003439
1. [Clinical significance of thrombocyte substitutes]. Schneider W. Bibl Haematol; 1971; 37():400-9. PubMed ID: 5003439 [No Abstract] [Full Text] [Related]
2. Complications of transfusion. Brzica SM. Int Anesthesiol Clin; 1982; 20(4):171-93. PubMed ID: 6293979 [No Abstract] [Full Text] [Related]
3. [Controversies in the therapy of childhood immune thrombocytopenia]. Gaedicke G, Imbach P, Küenzlen E, Kleihauer E. Dtsch Med Wochenschr; 1985 Aug 30; 110(35):1340-5. PubMed ID: 3896721 [No Abstract] [Full Text] [Related]
4. [The practical performance of blood platelet transfusion]. Bucher U, Kummer H. Schweiz Med Wochenschr; 1968 Oct 19; 98(42):1635-41. PubMed ID: 5748845 [No Abstract] [Full Text] [Related]
6. [Studies of the effectivity of thrombocyte concentrates by nuclear medical and coagulatory physiological methods]. Preussner S, Frick G, Schulz K, Konrad H, Kiencke H. Folia Haematol Int Mag Klin Morphol Blutforsch; 1971 Oct 19; 95(1):55-65. PubMed ID: 4104083 [No Abstract] [Full Text] [Related]
7. In vitro platelet phagocytosis by splenic leukocytes in idiopathic thrombocytopenic purpura. McMillan R, Longmire RL, Tavassoli M, Armstrong S, Yelenosky R. N Engl J Med; 1974 Jan 31; 290(5):249-51. PubMed ID: 4855568 [No Abstract] [Full Text] [Related]
8. [Errors of treatment by blood transfusions and plasma substitutes]. Kornobis J, Parkitna-Cegła Z, Swiatek B, Knap J, Morawski A. Wiad Lek; 1979 Sep 15; 32(18):1341-4. PubMed ID: 116428 [No Abstract] [Full Text] [Related]
9. [Treatment of autoimmune thrombocytopenic purpura]. Cajozzo A, Perricone R. Minerva Med; 1982 Apr 28; 73(18):1179-83. PubMed ID: 7200576 [No Abstract] [Full Text] [Related]
10. [The clinical effect of thrombocyte transfusions. Testing of the efficiency of the platelet concentrations produced by the Swiss Red Cross]. Hussain-Autenried I, Bucher U. Schweiz Rundsch Med Prax; 1972 Mar 14; 61(11):337-46. PubMed ID: 5063116 [No Abstract] [Full Text] [Related]
11. [Immunological platelet disorders]. Antonaci V. Minerva Med; 1971 May 23; 62(41):2085-92. PubMed ID: 5104040 [No Abstract] [Full Text] [Related]
12. Use of "compatible" platelet transfusions in treatment of congenital isoimmune thrombocytopenic purpura. Adner MM, Fisch GR, Starobin SG, Aster RH. N Engl J Med; 1969 Jan 30; 280(5):244-7. PubMed ID: 5812507 [No Abstract] [Full Text] [Related]
15. [Acute complications of transfusion--from the viewpoint of the clinical practitioner]. Hennemann HH. Med Klin; 1974 Aug 23; 69(34):1352-8. PubMed ID: 4214986 [No Abstract] [Full Text] [Related]
16. Treatment of disorders of blood platelets. Jackson DP. Mod Treat; 1968 Mar 23; 5(2):423-42. PubMed ID: 5690338 [No Abstract] [Full Text] [Related]
17. [Therapeutic measures after transfusion of incompatible blood]. Gaerisch F, Usbeck W, Dieterich F. Folia Haematol Int Mag Klin Morphol Blutforsch; 1966 Mar 23; 85(2):178-89. PubMed ID: 4167549 [No Abstract] [Full Text] [Related]
18. [Therapy of hemorrhagic diathesis]. Voss D. Minerva Med; 1972 Feb 24; 63(14):834-6. PubMed ID: 4536834 [No Abstract] [Full Text] [Related]